Promising early results from Parkinson’s vaccine study
A study in people with Parkinson’s has found that a vaccine can help slow down clumping of a protein known to be linked to the condition.
Successful spinal stimulation implant offers new hope
A new way to stimulate nerve cells in the spinal cord has helped improve balance and walking in one individual with Parkinson’s.
Parkinson’s UK awards over £1.8m to fund more vital research
New funding for projects tackling our understanding of Parkinson’s and projects exploring new drugs for the future.
We’re investing in Parkinson’s research in Scotland
We’re funding 2 projects at the University of Edinburgh which are investigating potential causes of Parkinson’s.
Breaking through barriers for Black History Month
This Black History Month we’re sharing stories from members of the community who are advocating for better inclusion of Black people in Parkinson’s research.
Loneliness linked to increased risk of developing Parkinson’s
Researchers followed almost half a million people for 15 years and found a potential link between feelings of loneliness and a greater risk of Parkinson’s.
Report your medication side effects through the Yellow Card scheme
We’re promoting the Yellow Card scheme to the Parkinson’s community, to make sure everyone knows where to report any medication side effects they may experience.
Next phase of cannabidiol (CBD) trial for Parkinson’s non-motor symptoms needs participants in the UK
The study builds on the results from the pioneering Parkinson’s UK funded trial launched in 2019.
New risk factor for Parkinson’s identified among people of African descent
A global collaboration of researchers has found a specific gene change is a risk factor for Parkinson’s unique to the Black African community.